BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 25933287)

  • 1. The PGE2/IL-10 Axis Determines Susceptibility of B-1 Cell-Derived Phagocytes (B-1CDP) to Leishmania major Infection.
    Arcanjo AF; LaRocque-de-Freitas IF; Rocha JD; Zamith D; Costa-da-Silva AC; Nunes MP; Mesquita-Santos FP; Morrot A; Filardy AA; Mariano M; Bandeira-Melo C; DosReis GA; Decote-Ricardo D; Freire-de-Lima CG
    PLoS One; 2015; 10(5):e0124888. PubMed ID: 25933287
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulatory B cells shape the development of Th2 immune responses in BALB/c mice infected with Leishmania major through IL-10 production.
    Ronet C; Hauyon-La Torre Y; Revaz-Breton M; Mastelic B; Tacchini-Cottier F; Louis J; Launois P
    J Immunol; 2010 Jan; 184(2):886-94. PubMed ID: 19966209
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mesenchymal stem cells alter macrophage immune responses to Leishmania major infection in both susceptible and resistance mice.
    Dameshghi S; Zavaran-Hosseini A; Soudi S; Shirazi FJ; Nojehdehi S; Hashemi SM
    Immunol Lett; 2016 Feb; 170():15-26. PubMed ID: 26703818
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of IL-10 in promoting disease progression in leishmaniasis.
    Kane MM; Mosser DM
    J Immunol; 2001 Jan; 166(2):1141-7. PubMed ID: 11145695
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Propionibacterium acnes induces an adjuvant effect in B-1 cells and affects their phagocyte differentiation via a TLR2-mediated mechanism.
    Gambero M; Teixeira D; Butin L; Ishimura ME; Mariano M; Popi AF; Longo-Maugéri IM
    Immunobiology; 2016 Sep; 221(9):1001-11. PubMed ID: 27233619
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Depletion of peritoneal CD5+ B cells has no effect on the course of Leishmania major infection in susceptible and resistant mice.
    Babai B; Louzir H; Cazenave PA; Dellagi K
    Clin Exp Immunol; 1999 Jul; 117(1):123-9. PubMed ID: 10403925
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of phospholipase A2 from Crotalus durissus collilineatus on Leishmania (Leishmania) amazonensis infection.
    Passero LF; Laurenti MD; Tomokane TY; Corbett CE; Toyama MH
    Parasitol Res; 2008 Apr; 102(5):1025-33. PubMed ID: 18180953
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Macrophage interactions with neutrophils regulate Leishmania major infection.
    Ribeiro-Gomes FL; Otero AC; Gomes NA; Moniz-De-Souza MC; Cysne-Finkelstein L; Arnholdt AC; Calich VL; Coutinho SG; Lopes MF; DosReis GA
    J Immunol; 2004 Apr; 172(7):4454-62. PubMed ID: 15034061
    [TBL] [Abstract][Full Text] [Related]  

  • 9. B-cell outgrowth and ligand-specific production of IL-10 correlate with Th2 dominance in certain parasitic diseases.
    Palanivel V; Posey C; Horauf AM; Solbach W; Piessens WF; Harn DA
    Exp Parasitol; 1996 Nov; 84(2):168-77. PubMed ID: 8932766
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetically resistant mice lacking interleukin-12 are susceptible to infection with Leishmania major and mount a polarized Th2 cell response.
    Mattner F; Magram J; Ferrante J; Launois P; Di Padova K; Behin R; Gately MK; Louis JA; Alber G
    Eur J Immunol; 1996 Jul; 26(7):1553-9. PubMed ID: 8766560
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of interleukin-4 and prostaglandin E2 in Leishmania amazonensis infection of BALB/c mice.
    Guimarães ET; Santos LA; Ribeiro dos Santos R; Teixeira MM; dos Santos WL; Soares MB
    Microbes Infect; 2006 Apr; 8(5):1219-26. PubMed ID: 16531090
    [TBL] [Abstract][Full Text] [Related]  

  • 12. How to B(e)-1 Important Cell During
    Firmino-Cruz L; Decote-Ricardo D; Gomes DCO; Morrot A; Freire-de-Lima CG; de Matos Guedes HL
    Front Cell Infect Microbiol; 2019; 9():424. PubMed ID: 31993374
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunological factors governing resistance and susceptibility of mice to Leishmania major infection.
    Aguilar-Torrentera F; Carlier Y
    Rev Latinoam Microbiol; 2001; 43(3):135-42. PubMed ID: 17061500
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effective clearance of intracellular Leishmania major in vivo requires Pten in macrophages.
    Kuroda S; Nishio M; Sasaki T; Horie Y; Kawahara K; Sasaki M; Natsui M; Matozaki T; Tezuka H; Ohteki T; Förster I; Mak TW; Nakano T; Suzuki A
    Eur J Immunol; 2008 May; 38(5):1331-40. PubMed ID: 18398930
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Leishmania major: differential resistance to infection in C57BL/6 (high interferon-alpha/beta) and congenic B6.C-H-28c (low interferon-alpha/beta) mice.
    Shankar AH; Morin P; Titus RG
    Exp Parasitol; 1996 Nov; 84(2):136-43. PubMed ID: 8932763
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pegylated bisacycloxypropylcysteine, a diacylated lipopeptide ligand of TLR6, plays a host-protective role against experimental Leishmania major infection.
    Pandey SP; Chandel HS; Srivastava S; Selvaraj S; Jha MK; Shukla D; Ebensen T; Guzman CA; Saha B
    J Immunol; 2014 Oct; 193(7):3632-43. PubMed ID: 25194056
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin-4 (IL-4) and IL-10 collude in vaccine failure for novel exacerbatory antigens in murine Leishmania major infection.
    Roberts MT; Stober CB; McKenzie AN; Blackwell JM
    Infect Immun; 2005 Nov; 73(11):7620-8. PubMed ID: 16239566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Could a B-1 cell derived phagocyte "be one" of the peritoneal macrophages during LPS-driven inflammation?
    Popi AF; Osugui L; Perez KR; Longo-Maugéri IM; Mariano M
    PLoS One; 2012; 7(3):e34570. PubMed ID: 22479646
    [TBL] [Abstract][Full Text] [Related]  

  • 19. B-1 Cells May Drive Macrophages Susceptibility to
    da Rocha RFDB; LaRocque-de-Freitas IF; Arcanjo AF; Logullo J; Nunes MP; Freire-de-Lima CG; Decote-Ricardo D
    Front Microbiol; 2019; 10():1598. PubMed ID: 31338088
    [TBL] [Abstract][Full Text] [Related]  

  • 20. c-Rel promotes type 1 and type 17 immune responses during Leishmania major infection.
    Reinhard K; Huber M; Wostl C; Hellhund A; Toboldt A; Abass E; Casper B; Joeris T; Herr C; Bals R; Steinhoff U; Lohoff M; Visekruna A
    Eur J Immunol; 2011 May; 41(5):1388-98. PubMed ID: 21469108
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.